To assess the drug-drug interaction with pangenotypic direct-acting antivirals in patients with hepatitis C
Latest Information Update: 20 Oct 2020
At a glance
- Drugs Glecaprevir/pibrentasvir (Primary) ; Sofosbuvir/velpatasvir (Primary) ; Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
Most Recent Events
- 29 Aug 2020 Results presented at The International Liver Congress 2020
- 24 Feb 2020 New trial record